Consensus Valerio Therapeutics Börse Stuttgart

Equities

C4X

FR0010095596

Market Closed - Börse Stuttgart Other stock markets 02:30:04 11/06/2024 pm IST			5-day change	1st Jan Change
0.0974 ^EUR	+0.21%		-1.42%	-36.05%

22/05	Valerio Therapeutics S.A. Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial	CI
30/04	Valerio Therapeutics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on Valerio Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

15726c83763a768007465d515a.eTvPaxdEpQDjaSfJ8dPMowngbmN2INmRIbHDxx3jOKE.EGGdBU92xnqbOGy_roOE_DGoIQU_DZr5EtWqilWMb_QIUK4pUHHkeKxYbg~3dfd486351e66fa3679f6b5e8b5a9200

Analyst Recommendations on Valerio Therapeutics

Onxeo : Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation	29/20/29	PU
Bryan Garnier & Co Initiates Coverage of Onxeo with a “Buy” Recommendation	27/20/27	GL
Onxeo : Bryan Garnier & Co Initiates the Coverage of Onxeo with a “Buy” Recommendation	27/20/27	BU

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.1076 EUR

Average target price

1.2 EUR

Spread / Average Target

+1,015.24%

High Price Target

1.2 EUR

Spread / Highest target

+1,015.24%

Low Price Target

1.2 EUR

Spread / Lowest Target

+1,015.24%

Consensus detail

Consensus revision (last 18 months)

Annual profits - Rate of surprise

Company calendar